CHARGE syndrome: moleculair diagnosis, clinical aspects and its overlap with Kallmann syndrome
PhD ceremony: Ms. J.E.H. van Kammen-Bergman, 16.15 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: CHARGE syndrome: moleculair diagnosis, clinical aspects and its overlap with Kallmann syndrome
Promotor(s): prof. C.M.A. van Ravenswaaij-Arts, prof. R.M.W. Hofstra
Faculty: Medical Sciences
The focus of the thesis is on two rare hereditary syndromes: CHARGE syndrome and Kallmann syndrome. Patients with these syndromes may present with a smell deficit and absent pubertal maturation. CHARGE syndrome is caused by mutations in the CHD7 gene, but the genetics of Kallmann syndrome is still largely unknown. We developed a database containing all known CHD7 mutations (www.CHD7.org). In addition, a classification system was created to predict whether certain ‘mild’ CHD7 variants cause the disease. We showed that a smell deficit, genital anomalies, and decreased fertility are present in some mice with CHARGE syndrome. In patients with CHARGE syndrome, we demonstrated that a smell deficit is always correlated with absent pubertal maturation. A smell test can therefore predict whether a child with CHARGE syndrome will enter puberty spontaneously, providing the opportunity for timely hormone replacement therapy. Furthermore, we identified risk factors for sudden death in CHARGE syndrome and developed recommendations to prevent premature demise. We showed that some patients with a CHD7 mutation have very few features of CHARGE syndrome, whereas others have many/severe anomalies. A guideline was compiled indicating in which patients CHD7 analysis is useful. Also, we proposed recommendations for follow-up and treatment of patients with a CHD7 mutation. We showed that some patients with Kallmann syndrome carry a CHD7 mutation. These patients often had additional features of CHARGE syndrome.
Last modified: | 13 March 2020 01.12 a.m. |
More news
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. Jouke de Vries, the chair of the Executive Board, looks back.
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.